Abstract
Introduction COVID-19 pandemic condition affects the adherence of PLWHA in taking antiretroviral drugs. People with Lost to Follow-up (LTFU) were an average of 26 %, The feared impact is the high mortality rate and decreased productivity, visits of PLWHA patients to M Jamil Hospital come from all regions in West Sumatra to the southern provinces of Jambi and Bengkulu. This study aimed to determine factors that influence patient non-Adherence during the COVID-19 pandemic.
Method This study was conducted by exploring the experiences of patients and health workers by observing adherence to taking antiretroviral, 34 informant: 25 patients, 5 NGOs, and 4 health workers, The data were collected from September 6th to October 9th 2021, Analysis data using N VIVO 12.
Results Patients in taking medication during the COVID-19 pandemic were feeling bored, most of the patient lived was so far, so patients often asked for help from NGOs to take medication. Forgetfulness, busyness, and fear of being exposed to COVID-19. Then, the economic factor, due to the large number of layoffs, and the absence of BPJS insurance affects compliance, while the factors of stigma, stress, feeling well are slightly expressed by patients. It turns out that the Covid-19 condition affects patients to come for treatment to the hospital. In addition to drug side effects, dizziness, nausea, and vomiting also affect medication adherence. The role of NGOs in providing information and education as well as motivating and taking medication during the COVID-19 condition is very important.
Conclusion The most common causes of non-compliance from loss to follow-up during the COVID-19 pandemic are; bored, far from home, forgetful, and economic factors for fear of covid-19. Most of the side effects of drugs are dizziness, and nausea and vomiting so that the role of NGOs is important in helping patients take medication.
Strength and limitation of this study
➢ This qualitative research is about medication adherence during the covid-19
➢ The factors that influence patient adherence to taking ART are different during this covid-19 pandemic, namely the distance from which they live has an effect on patients wanting to take medication, so the role of NGOs in sending drugs is very important, according to the doctors approval, after the next 3 months the patient is required to come, this is never happened before the Covid-19 condition, Patients adherence are very dependent on the patient’s self-awareness to live in the long term, the convenience has been provided by M Jamil Hospital by making it easy to send drugs to the patient’s own address.
➢ This qualitative analysis using N vivo 12, which has now developed into N vivo 14
➢ Patient recruitment is divided into two, namely obedient and non-compliant patients, but the patient’s answers are almost the same.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
this study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research had been obtained permission from the Ethics Committee of. M.Jamil Hospital Padang No. 363/KEPK/2021. All study participants provided written informed consent and had an understanding of the study. Informed consent was given to informants at the time of the patient face it, There is no conflict of interest here in this study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript